Generic Name: pyrazinamide (peer a ZIN a mide)
What is pyrazinamide?
Pyrazinamide is an antibiotic that fights bacteria.
Pyrazinamide is used to treat tuberculosis (TB) in adults and children.
Pyrazinamide must be used with other TB medicines. Tuberculosis can become resistant to treatment if pyrazinamide is used alone. Take all your medicines as prescribed by your doctor.
Pyrazinamide may also be used for purposes not listed in this medication guide.
What is the most important information I should know about pyrazinamide?
You should not use pyrazinamide if you have active gout or severe liver disease.
What should I discuss with my healthcare provider before taking pyrazinamide?
You should not use pyrazinamide if you are allergic to it, or if you have:
active gout; or
severe liver disease.
To make sure pyrazinamide is safe for you, tell your doctor if you have:
HIV or AIDS;
if you drink large amounts of alcohol.
Your doctor will check your liver enzymes and uric acid levels before you start treatment, to make sure you can safely take pyrazinamide.
It is not known whether pyrazinamide will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.
Pyrazinamide can pass into breast milk and may harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
How should I take pyrazinamide?
Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Tuberculosis must be treated over a long period of time (up to 6 months or longer).
Pyrazinamide is given in combination with other medications and should not be used alone. You may need to take pyrazinamide for only the first 2 months of your full course of treatment.
Pyrazinamide is usually taken once per day. However, some people take the medicine only 2 times per week.
Follow your doctor's dosing instructions very carefully.
Use this medicine for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Skipping doses may also increase your risk of further infection that is resistant to antibiotics. Pyrazinamide will not treat a viral infection such as the flu or a common cold.
Tell your doctor if you have any changes in weight. Pyrazinamide doses are based on weight (especially in children), and any changes may affect the dose.
This medicine can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using pyrazinamide.
Store at room temperature away from moisture and heat.
Keep the bottle tightly closed when not in use.
What happens if I miss a dose?
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking pyrazinamide?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Pyrazinamide side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
joint pain or swelling;
easy bruising or bleeding (nosebleeds, bleeding gums);
gout flare-up symptoms--joint pain, stiffness, redness, or swelling (especially at night); or
liver problems--nausea, upper stomach pain, itching, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Common side effects may include:
joint or muscle pain;
nausea, vomiting; or
loss of appetite.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Pyrazinamide dosing information
Usual Adult Dose for Tuberculosis -- Active:
15 to 30 mg/kg (up to 2 g) orally once a day in combination with three other antituberculous drugs for the initial 2 months of a 6-month or 9-month treatment regimen, until drug susceptibility tests are known. An alternate dosing regimen of 50 to 75 mg/kg (up to 3 g) orally twice a week may be used after 2 weeks of daily therapy to increase patient compliance.
Alternatively, the CDC, The American Thoracic Society, and the Infectious Diseases Society of America suggest the following dosing based on estimated lean body weight:
40 to 45 kg: 1000 mg
56 to 75 kg: 1500 mg
76 to 90 kg: 2000 mg
Twice weekly dosing:
40 to 55 kg: 2000 mg
56 to 75 kg: 3000 mg
76 to 90 kg: 4000 mg
Thrice weekly dosing:
40 to 55 kg: 1500 mg
56 to 75 kg: 2500 mg
76 to 90 kg: 3000 mg
Usual Adult Dose for Tuberculosis -- Latent:
A public health expert should be consulted prior to the use of the combination regimen with rifampin.
15 to 20 mg/kg, based on actual body weight (lean), orally once daily (maximum 2 g) for 2 months. Alternatively, a dosage of 50 mg/kg may be administered orally twice-weekly (maximum 4 g).
Usual Pediatric Dose for Tuberculosis -- Active:
(Used as part of a multidrug regimen. Treatment regimens consist of an initial 2-month phase, followed by a continuation phase of 4 or 7 additional months. Frequency of dosing may differ depending on phase of therapy)
Infants, Children less than 40 kg and Adolescents 14 years and younger and less than 40 kg:
Daily therapy: 15 to 30 mg/kg/dose (maximum: 2 g/dose) once daily
Directly observed therapy (DOT): 50 mg/kg/dose (maximum: 2 g/dose) twice weekly
Daily therapy: 20 to 40 mg/kg/dose once daily (maximum: 2 g/day)
What other drugs will affect pyrazinamide?
Other drugs may interact with pyrazinamide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
More about pyrazinamide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: miscellaneous antituberculosis agents
Related treatment guides
Where can I get more information?
- Your pharmacist can provide more information about pyrazinamide.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 4.01.
Date modified: March 15, 2017
Last reviewed: February 01, 2016